(WASHINGTON, DC) BYOD supporters are in luck: If you want to see the bring-your-own-device movement get better, there is new data showing that industry leaders aren’t as opposed to BYOD as you may think.
Applied Clinical Trials recently published a study that surveyed lead eCOA providers (and those related) on their opinions. mProve Founder and CEO Jeff Lee coauthored the article with Bill Byrom of ICON and other thought leaders within ICON and Medidata.
The authors lead a growing effort to push the BYOD concept forward and begin using it in mainstream clinical trials. The movement has been stalled for years at what Lee calls “the BYOD stalemate”: the FDA cannot issue any statements on the validity of BYOD-sourced data without seeing drug studies that use it; conversely, pharma companies are unwilling to risk the success of their clinical trials on a data collection method that the FDA hasn’t rubber-stamped. Byrom and Lee are some of the BYOD proponents trying to break through the red tape.
To shed light on the industry climate, the authors report on a survey taken by several dozen professionals at CROs, eCOA vendors, and biopharmaceutical companies. The survey asked a series of questions about some of the doubts surrounding BYOD: that subjects may lose or change their device, that the data collected may not be private, that site staff would be burdened, that the patient would delete or corrupt the app, etc. (more…)
Washington, D.C. (September 5, 2014) – mProve Health, a leader in providing mobile technology services to the life sciences sector, announces the addition of T. Hephner to its team. Hephner has joined mProve as Vice President of Business Development.
Mr. Hephner brings over 15 years of business development, sales and marketing experience to mProve Health. A co-founder of Praxis, a leading patient recruitment provider, and a seasoned veteran of the clinical research world, Mr. Hephner will bring these experiences to one of the fastest growing companies in the life sciences arena.
Mr. Hephner is joining the team during a period of major expansion by mProve. Since its founding in 2010, mProve has steadily grown into a leadership position in the mHealth field, with a focus on the use of mobile devices to create clinical study efficiencies in the areas of patient recruitment, retention and in the collection of patient-reported outcomes. With revolutionary products and applications that allow for usage of participants’ own mobile devices, mProve has emerged as an industry leader in patient engagement products via mobile platform and is leading the way in next generation clinical trials.